PharmD Live
We provide Medicare Seniors 24/7 pharmacist access for medication management
Analytics
Raised to Date: $95,080
Aggregate Commitments $
Wefunder
09/01/2020
04/01/2021
$250,000
$1,070,000
$100
Equity - Preferred
RegCF
Seed
$9,130,000
Weekly Commitments $
Active
01/17/2021
72
38%
9%
$689
District of Columbia,
Healthcare & Pharmaceuticals
HealthTech
B2B2C
High
Low
PharmD Live, with a pre-money valuation of $9.13 million, is raising funds on Wefunder. It is a telehealth company focused on medication risk and disease management, especially for chronically ill and old patients. The technology enhances patient care by providing 24/7 access to healthcare, self-management of health conditions, and better health outcomes. Cynthia Chioma Nwaubani founded PharmD Live in April 2019. The proceeds of the current crowdfunding campaign, with a minimum goal of $250,000 and a maximum goal of $1,070,000, will be used for marketing and hiring staff to support new clients. PharmD Live also has a patent-pending technology platform for predictive medication side-effect profiling.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-153,525 |
$0 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$0 |
$0 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$0 |
$0 |
|
Short-Term Debt |
$147,000 |
$0 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$147,000 |
$0 |
Ratings
Ratings Platform - Beta Trial
Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.
For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.Other Deals
Millennial Fertility Co. on NetCapital
The Millennial Fertility Co. team has been selected as a “Deal to Watch” by KingsCrowd. This distinction is…
Biopact on Equifund CFP
Biopact has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…
Neurotez Inc. on NetCapital
Neurotez has been selected as a “Deal To Watch” by KingsCrowd. This distinction is reserved for deals selected…